APOE and Alzheimer disease: The R47H variant of triggering receptor expressed on myeloid cells 2 (TREM2) increased the risk of developing AD by approximately 2- to 4- fold [6, 7], similar to what has been found in patients with one copy of APOE (encoding apolipoprotein E (APOE) ε4).